Logo image of OTLK

OUTLOOK THERAPEUTICS INC (OTLK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OTLK - US69012T3059 - Common Stock

0.4488 USD
-0.05 (-9.73%)
Last: 1/28/2026, 8:04:17 PM
0.4487 USD
0 (-0.02%)
After Hours: 1/28/2026, 8:04:17 PM
Fundamental Rating

1

Overall OTLK gets a fundamental rating of 1 out of 10. We evaluated OTLK against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of OTLK have multiple concerns. OTLK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year OTLK has reported negative net income.
  • OTLK had a negative operating cash flow in the past year.
  • OTLK had negative earnings in each of the past 5 years.
  • In the past 5 years OTLK always reported negative operating cash flow.
OTLK Yearly Net Income VS EBIT VS OCF VS FCFOTLK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -335.90%, OTLK is not doing good in the industry: 91.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -335.9%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OTLK Yearly ROA, ROE, ROICOTLK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K -1K -1.5K

1.3 Margins

  • With a decent Gross Margin value of 3.80%, OTLK is doing good in the industry, outperforming 72.00% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for OTLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OTLK Yearly Profit, Operating, Gross MarginsOTLK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

0

2. Health

2.1 Basic Checks

  • OTLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for OTLK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OTLK Yearly Shares OutstandingOTLK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
OTLK Yearly Total Debt VS Total AssetsOTLK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -59.03, we must say that OTLK is in the distress zone and has some risk of bankruptcy.
  • OTLK has a worse Altman-Z score (-59.03) than 91.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -59.03
ROIC/WACCN/A
WACC8.2%
OTLK Yearly LT Debt VS Equity VS FCFOTLK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

2.3 Liquidity

  • OTLK has a Current Ratio of 0.38. This is a bad value and indicates that OTLK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OTLK has a Current ratio of 0.38. This is amonst the worse of the industry: OTLK underperforms 91.62% of its industry peers.
  • OTLK has a Quick Ratio of 0.38. This is a bad value and indicates that OTLK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of OTLK (0.31) is worse than 91.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.31
OTLK Yearly Current Assets VS Current LiabilitesOTLK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 82.64% over the past year.
EPS 1Y (TTM)82.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, OTLK will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.45% on average per year.
  • OTLK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 57.52% yearly.
EPS Next Y-80.52%
EPS Next 2Y-11.84%
EPS Next 3Y17.24%
EPS Next 5Y14.45%
Revenue Next Year246.16%
Revenue Next 2Y196.28%
Revenue Next 3Y50.35%
Revenue Next 5Y57.52%

3.3 Evolution

OTLK Yearly Revenue VS EstimatesOTLK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2025 2026 2027 2028 2029 2030 2031 2032 2033 20M 40M 60M
OTLK Yearly EPS VS EstimatesOTLK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -100 -200 -300

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OTLK. In the last year negative earnings were reported.
  • Also next year OTLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTLK Price Earnings VS Forward Price EarningsOTLK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTLK Per share dataOTLK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • OTLK's earnings are expected to grow with 17.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.84%
EPS Next 3Y17.24%

0

5. Dividend

5.1 Amount

  • No dividends for OTLK!.
Industry RankSector Rank
Dividend Yield 0%

OUTLOOK THERAPEUTICS INC / OTLK FAQ

What is the ChartMill fundamental rating of OUTLOOK THERAPEUTICS INC (OTLK) stock?

ChartMill assigns a fundamental rating of 1 / 10 to OTLK.


Can you provide the valuation status for OUTLOOK THERAPEUTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to OUTLOOK THERAPEUTICS INC (OTLK). This can be considered as Overvalued.


How profitable is OUTLOOK THERAPEUTICS INC (OTLK) stock?

OUTLOOK THERAPEUTICS INC (OTLK) has a profitability rating of 1 / 10.


Can you provide the financial health for OTLK stock?

The financial health rating of OUTLOOK THERAPEUTICS INC (OTLK) is 0 / 10.